Şunu aradınız:: fondaparinuuksin (Fince - İngilizce)

fondaparinuuksin al
the efficacy and safety of fondaparinux have not ro

fondaparinuuksin tiedetään
fondaparinux is known to be

fondaparinuuksin tehoa m
the efficacy and safety of fondaparinux have not ro

fondaparinuuksin anto voidaan el
in stemi or ua/ nstemi patients who are to undergo coronary artery bypass graft (cabg) surgery, fondaparinux where possible, should not be given during the 24 hours before surgery and may be ct

fondaparinuuksin käyttöä tulee kuitenkin harkita
however, the use of fondaparinux should be m

fondaparinuuksin eliminaatio vähenee painon mukaan.
elimination of fondaparinux decreases with weight.

fondaparinuuksin kliininen tutkimusohjelma laskimotromboembolian hoidossa suunniteltiin
the fondaparinux clinical program in treatment of venous thromboembolism was designed to lp

fondaparinuuksin tiedetään erittyvän pääasiassa munuaisten kautta.
fondaparinux is known to be excreted mainly by the kidney.

fondaparinuuksin kliininen tutkimusohjelma laskimotromboembolian hoidossa suunniteltiin el
fondaparinux does not cross-react with sera from patients with heparin-induced thrombocytopaenia.

tuloksena fondaparinuuksin pitoisuus ilmaistaan milligrammoina (mg).
as a result, the concentration of fondaparinux is expressed as milligrams (mg).

iäkkäillä terveillä tutkimushenkilöillä fondaparinuuksin farmakokinetiikka on lineaarista el
in elderly healthy subjects, pharmacokinetics of fondaparinux is linear in the range of 2 to 8 mg by

jakautuminen fondaparinuuksin jakautumistilavuus on pieni (7­11 litraa) .
distribution the distribution volume of fondaparinux is limited (7-11 litres) .

fondaparinuuksin antitromboottinen vaikutus johtuu hyytymistekijä xa: n antitrombiini iii
the antithrombotic activity of fondaparinux is the result of antithrombin iii (antithrombin) mediated selective inhibition of factor xa.

fondaparinuuksin anto voidaan aloittaa uudelleen 48 tunnin kuluttua leikkauksesta.
in stemi or ua/ nstemi patients who are to undergo coronary artery bypass graft (cabg) surgery, fondaparinux where possible, should not be given during the 24 hours before surgery and may be restarted 48 hours post-operatively.

tämän seurauksena fondaparinuuksin munuaispuhdistuma suurenee.lievää tai kohtalaista maksan
consequently, unbound concentrations of fondaparinux are expected to be unchanged in patients with mild to moderate hepatic impairment, and therefore, no dose adjustment is necessary based on pharmacokinetics.

lonkkamurtumapotilailla, liittyen korkeampaan ikään, fondaparinuuksin vakaan tilan plasmakonsentraatiot ovat:
in hip fracture patients, associated with their increased age, fondaparinux steady state plasma concentrations are: